SLC1A2 and Parkinson disease: Moreover, selective knockdown of astrocytic EAAT2 in the substantia nigra or striatum can induce molecular and behavioral changes reminiscent of PD, including neuronal loss, astrogliosis, abnormal gait, poorer motor performance, and depression-like features [27,28].